{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-079788","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2024-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.066952+00:00","generated_at":"2026-05-31T03:59:02.017323+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nutriband announces $1 million share repurchase program; reaffirms AVERSA Fentanyl NDA timeline","bullets":["Share buyback program authorizes repurchase of up to $1,000,000 of common stock.","Company had 11,106,185 shares outstanding as of September 16, 2024.","Maintains target to submit AVERSA Fentanyl NDA to FDA in Q1/Q2 2025.","Repurchase program effective immediately; no expiration date disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-079788","json":"https://secwatch.observer/filing/0001213900-24-079788.json","markdown":"https://secwatch.observer/filing/0001213900-24-079788.md","text":"https://secwatch.observer/filing/0001213900-24-079788.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390024079788/0001213900-24-079788-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390024079788/ea0215009-8k_nutri.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:59:02.017323+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}